The research aims to explore the role of TMPO-AS1 and hsa-let-7b-5p in lung adenocarcinoma's immune and transcriptional landscape.
Analysis of expression levels of TMPO-AS1 in lung adenocarcinoma samples
Examination of the correlation between TMPO-AS1 and clinical outcomes
Investigation of immune landscape alterations associated with TMPO-AS1 overexpression
TMPO-AS1 is significantly overexpressed in lung adenocarcinoma cases.
Higher TMPO-AS1 expression correlates with poorer clinical outcomes.
TMPO-AS1 serves as a potential molecular classifier for lung adenocarcinoma.
Abstract
The study concludes that TMPO-AS1 is overexpressed in cases of LUAD, highlighting its potential as a molecular classifier for LUAD and a prognostic biomarker associated with poor clinical outcomes.